| |
| | Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment -- Ravina et al. 60 (8): ... |
 | | Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment -- Ravina et al. |
 | | Ravina, Hart, Murphy, and Marler) National Institutes of Health, Rockville, MD; Department of Pharmacology (Dr. Fagan), Medical College of Georgia, Augusta; Departments of Pharmacy and Neurology (Dr. Hovinga), Cleveland Clinic Foundation, OH; and Johns Hopkins University School of Medicine (Dr. Dawson), Baltimore, MD. |
 | | B. Tilley, Y. Palesch, K. Kieburtz, B. Ravina, P. Huang, J. Elm, K. Shannon, G. Wooten, C. Tanner, G. Goetz, and on behalf of the NET-PD Investigators |
| www.neurology.org /cgi/content/abstract/60/8/1234 (838 words) |
|